● TIER 3 — Information onlyGRADE BAndrogens / AAS
Oxandrolone
AAS. Research verification: Yes (TGA pending). 2 human study record(s) in the FitClinicMD studies database.
GOALS · Muscle / body composition
FDA status
FDA withdrew approval Jun 2023; determined withdrawn for safety/effectiveness (liver risks)
Compounding (503A/503B)
Not available.
DEA
DEA Schedule III.
WADA (sport)
S1 Anabolic agents
Mechanism
Oral AAS.
Human evidence · 2
Children with severe burns: muscle mass/function. The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
HIV wasting men RCT. Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
Reference only. This page summarizes publicly available regulatory and research information about Oxandrolone. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.
Related compounds
● TIER 1GRADE A
Testosterone (all esters, TRT)
AR agonist; esters (cypionate, enanthate, undecanoate), gels, pellets, oral TU.
● TIER 2GRADE B
Nandrolone & other AAS
AR agonist (19-nortestosterone).
● TIER 3GRADE D
Oral-Turinabol (4-chlorodehydromethyltestosterone) — GDR history [NEW, sport]
Origin: East Germany (VEB Jenapharm).